GYN SPORE Investigators Meeting (Abstract Submission)
12 submissions
Created | First Name | Last Name | Phone | Topic Classification | Abstract Title | First Author First Name | First Author Last Name | Affiliation | List of Additional Authors | Upload Abstract | Special Characters Included? | Abstract Review Status | Operations | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sat, 08/03/2024 - 14:19 | Sara | Corvigno | SCorvigno@mdanderson.org | Session 5: Tumor biology, early detection, and prevention | Longitudinal genomic profiling of chemotherapy-related CHIP variants in patients with ovarian cancer | Sara | Corvigno | The University of Texas MD Anderson Cancer Center |
|
SPORE 2024 Corvigno.docx30.55 KB
|
No | |||
Sat, 08/03/2024 - 13:33 | Charles | Ishak | caishak@mdanderson.org | 8329460841 | Session 5: Tumor biology, early detection, and prevention | Endogenous retrotransposons and the viral mimicry response during early ovarian tumorigenesis | Charles | Ishak | University of Texas MD Anderson Cancer Center |
2024_NCI_Abstract_Ishak.docx17.11 KB
|
No | |||
Sat, 08/03/2024 - 12:38 | Kimberly | Levinson | klevins1@jhmi.edu | 4104199715 | Session 6: Translating Innovation to Clinical trials | Therapeutic Vaccination with pNGL4aCRTE6E7L2 and Electroporation for the Elimination of HPV16+ High Grade Anogenital Dysplasia | Kimberly | Levinson | Johns Hopkins |
|
No | |||
Sat, 08/03/2024 - 11:32 | Teresa | Boitano | tlboitano@uabmc.edu | 5052213726 | Session 5: Tumor biology, early detection, and prevention | Provider Perspectives on the Transition to Primary HPV Testing for Cervical Cancer Screening | Peter | Ketch | UAB |
|
NCI.Spore_.abstract.tb_.docx16.18 KB
|
No | ||
Fri, 08/02/2024 - 15:25 | Kimberly | Leslie | kkleslie@salud.unm.edu | 3196212145 | Session 3: DNA repair and PARP inhibition | p53: The Guardian of the Genome Morphs into the Guardian of the Cancer Cell | Kimberly | Leslie | The University of New Mexico Comprehensive Cancer Center | No | ||||
Fri, 08/02/2024 - 15:07 | Vishal | Chandra | vishal-Chandra@ouhsc.edu | 4057196149 | Session 5: Tumor biology, early detection, and prevention | Utilizing GLP-1R Agonist for Endometrial Cancer Therapy | Vishal | Chandra | Gynecologic Oncology Section, Obstetrics and Gynecology Department, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. |
|
Chandra_OUHSC_Session 5.docx27.46 KB
|
No | ||
Fri, 08/02/2024 - 15:07 | T.-C. | Wu | wutc@jhmi.edu | Session 2: Combination therapies and Immunotherapy | SPORE in Cervical Cancer | T.-C. | Wu | Johns Hopkins University School of Medicine |
Wu_Johns Hopkins_Session#2.docx15.05 KB
|
No | ||||
Fri, 08/02/2024 - 13:34 | Bethany | Hannafon | bethany-hannafon@ouhsc.edu | 405-271-8001 | Session 2: Combination therapies and Immunotherapy | Oklahoma Nitrone – 007 (OKN-007) Targets Immunosuppressive and Inflammatory Pathways to Suppress Endometrial Cancer | Sugantha Priya | Elayapillai | Department of Obstetrics and Gynecology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center |
|
Yes | |||
Fri, 08/02/2024 - 10:53 | Rikki | Cannioto | rikki.cannioto@roswellpark.org | Session 5: Tumor biology, early detection, and prevention | Leveraging Novel Body Composition Indices and Immuno-Metabolomic Biomarkers to Disentangle the Obesity Paradox in Epithelial Ovarian Cancer | Rikki | Cannioto | Roswell Park |
|
No | ||||
Wed, 07/31/2024 - 08:36 | Ludmila | Szabova | lszabova@mail.nih.gov | Session 5: Tumor biology, early detection, and prevention | Evaluation of therapeutics for tumor prevention and treatment in genetically engineered mouse models for high grade ovarian cancer | Ludmila | Szabova | Frederick National Laboratory for Cancer Research |
|
Szabova_FNLCR_session 5.docx15.39 KB
|
No | |||
Sun, 07/07/2024 - 11:11 | Heather | Whitney | hwhitney@uchicago.edu | Session 5: Tumor biology, early detection, and prevention | Artificial intelligence for pre-operative assessment of adnexal lesions from ultrasound images |
Heather | Whitney | University of Chicago |
|
No | ||||
Sun, 06/30/2024 - 14:01 | David | Mutch | mutchd@Wustl.edu | 314-362-3181 | Session 2: Combination therapies and Immunotherapy | Route 66 Endometrial Cancer SPORE | David | Mutch | Washington University |
|
Yes |